The Long Pentraxin 3 and Its Role in Autoimmunity

Seminars in Arthritis and Rheumatism

Volumn 39, Issue 1, 2009, Pages 38-54

  Ortega Hernandez, Oscar Danilo ^a   Bassi, Nicola ^b   Shoenfeld, Yehuda ^c   Anaya, Juan Manuel ^d  

^a Unidad de Biología Celular y Molecular   (Colombia)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

apoptosis; autoimmunity; endothelial dysfunction; genetics; innate immunity; pentraxin 3

Indexed keywords

CYTOKINE; PENTRAXIN 3;

AMINO TERMINAL SEQUENCE; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR INFLAMMATION; CENTRAL NERVOUS SYSTEM; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; FERTILITY; GENE FUNCTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN STRUCTURE; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

AUTOIMMUNITY; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNITY, INNATE; SERUM AMYLOID P-COMPONENT; VASCULAR DISEASES;

EID: 67651062322     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2008.03.006     Document Type: Article

References (110)

1. Introna M., Alles V.V., Castellano M., Picardi G., De Gioia L., Bottazzi B., et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 87 (1996) 1862-1872
2. Coe J.E., Margossian S.S., Slayter H.S., and Sogn J.A. Hamster female protein. A new Pentraxin structurally and functionally similar to C-reactive protein and amyloid P component. J Exp Med 153 (1981) 977-991
3. Bottazzi B., Garlanda C., Salvatori G., Jeannin P., Manfredi A., and Mantovani A. Pentraxins as a key component of innate immunity. Curr Opin Immunol 18 (2006) 10-15
4. Han B., Mura M., Andrade C.F., Okutani D., Lodyga M., dos Santos C.C., et al. TNF alpha induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol 175 (2005) 8303-8311
5. Garlanda C., Hirsch E., Bozza S., Salustri A., De Acetis M., Nota R., et al. Nonredundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420 (2002) 182-186
6. Varani S., Elvin J.A., Yan C., DeMayo J., DeMayo F.J., Horton H.F., et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol 16 (2002) 1154-1167
7. Kravitz M.S., Pitashny M., and Shoenfeld Y. Protective molecules-C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J Clin Immunol 25 (2005) 582-591
8. Garlanda C., Bottazzi B., Bastone A., and Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23 (2005) 337-366
9. Inoue K., Sugiyama A., Reid P.C., Ito Y., Miyauchi K., Mukai S., et al. Establishment of a high sensitivity plasma assay for human pentraxin 3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 27 (2007) 161-167
10. Peri G., Introna M., Corradi D., Iacuitti G., Signorini S., Avanzini F., et al. PTX3. A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans Circulation 102 (2000) 636-641
11. Latini R., Maggioni A.P., Peri G., Gonzini L., Lucci D., Mocarelli P., et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110 (2004) 2349-2354
12. Fazzini F., Peri G., Doni A., Dell'Antonio G., Dal Cin E., Bozzolo E., et al. PTX3 in small vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 44 (2001) 2841-2850
13. Bottazzi B., Vouret-Craviari V., Bastone A., De Gioia L., Matteucci C., Peri G., et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 272 (1997) 32817-32823
14. Montovani A., Garlanda C., Otero K., Peri G., Vecchi A., and Bottazzi B. Membrane and soluble pattern recognition receptors: unique functions of the long pentraxin PTX3. Clin Exp All Rev 4 (2004) S150-S154
15. Srinivasan N., White H.E., Emsley J., Wood S.P., Pepys M.B., and Blundell T.L. Comparative analyses of pentraxins: implications for protomer assembly and ligand binding. Structure 2 (1994) 1017-1027
16. Cross A.S., Sakarya S., Rifat S., Held T.K., Drysdale B.E., Grange P.A., et al. Recruitment of murine neutrophils in vivo through endogenous sialidase activity. J Biol Chem 278 (2003) 4112-4120
17. Inforzato A., Peri G., Doni A., Garlanda C., Mantovani A., Bastone A., et al. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation. Biochemistry 45 (2006) 11540-11551
18. Nauta A.J., Bottazzi B., Mantovani A., Salvatori G., Kishore U., Schwaeble W.J., et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol 33 (2003) 465-473
19. Camara M., Boulnois G.J., Andrew P.W., and Mitchell T.J. A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect Immun 62 (1994) 3688-3695
20. Camozzi M., Rusnati M., Bugatti A., Bottazzi B., Mantovani A., Bastone A., et al. Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem 281 (2006) 22605-22613
21. Camozzi M., Zacchigna S., Rusnati M., Coltrini D., Ramirez-Correa G., Bottazzi B., et al. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Arterioscler Thromb Vasc Biol 25 (2005) 1837-1842
22. Franz S., Gaipl U.S., Munoz L.E., Sheriff A., Beer A., Kalden J.R., et al. Apoptosis and autoimmunity: when apoptotic cells break their silence. Curr Rheumatol Rep 8 (2006) 245-247
23. Navratil J.S., Liu C.C., and Ahearn J.M. Apoptosis and autoimmunity. Immunol Res 36 (2006) 3-12
24. Mahnke K., Johnson T.S., Ring S., and Enk A.H. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci 46 (2007) 159-167
25. Cocca B.A., Cline A.M., and Radic M.Z. Blebs and apoptotic bodies are B cell autoantigens. J Immunol 169 (2002) 159-166
26. Rovere P., Peri G., Fazzini F., Bottazzi B., Doni A., Bondanza A., et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen presenting dendritic cells. Blood 96 (2000) 4300-4306
27. Bijl M., Horst G., Bijzet J., Bootsma H., Limburg P.C., and Kallenberg C.G. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte derived macrophages. Arthritis Rheum 48 (2003) 248-254
28. Szalai A.J. C-Reactive protein (CRP) and autoimmune Disease: facts and conjetures. Clin Dev Immunol 11 (2004) 221-226
29. Schwalbe R.A., Dahlbäck B., Coe J.E., and Nelsestuen G.L. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 31 (1992) 4907-4915
30. Van Rossum A.P., Fazzini F., Limburg P.C., Manfredi A.A., Rovere-Querini P., Mantovani A., et al. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum 50 (2004) 2667-2674
31. Familian A., Zwart B., Huisman H.G., Rensink I., Roem D., Hordijk P.L., et al. Chromatin independent binding of serum amyloid P component to apoptotic cells. J Immunol 167 (2001) 647-654
32. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., et al. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34 (2004) 921-929
33. Patel V.A., Longacre A., Hsiao K., Fan H., Meng F., Mitchell J.E., et al. Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunity. J Biol Chem 281 (2006) 4663-4670
34. Wilson N.S., El-Sukkari D., and Villadangos J.A. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103 (2004) 2187-2195
35. Schnorrer P., Behrens G.M., Wilson N.S., Pooley J.L., Smith C.M., El-Sukkari D., et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci USA 103 (2006) 10729-10734
36. Baruah P., Propato A., Dumitriu I.E., Rovere-Querini P., Russo V., Fontana R., et al. The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumour antigens. Blood 107 (2006) 151-158
37. Mantovani A., Garlanda C., and Bottazzi B. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 21 (2003) S43-S47
38. Aoki C.A., Borchers A.T., Li M., Flavell R.A., Bowlus C.L., Ansari A.A., et al. Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun Rev 4 (2005) 450-459
39. Xu W., Roos A., Schlagwein N., Woltman A.M., Daha M.R., and van Kooten C. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107 (2006) 4930-4937
40. Wisniewski H.G., and Vilcek J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev 15 (2004) 129-146
41. Mukhopadhyay D., Asari A., Rugg M.S., Day A.J., and Fülöp C. Specificity of the tumor necrosis factor-induced protein 6-mediated heavy chain transfer from inter-alpha-trypsin inhibitor to hyaluronan: implications for the assembly of the cumulus extracellular matrix. J Biol Chem 279 (2004) 11119-11128
42. Scarchilli L.A., Camaioni A., Botazzi B., Negri V., Doni A., Deban L., et al. PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion. J Biol Chem 282 (2007) 30161-30170
43. Eisenbach M., and Giojalas L.C. Sperm guidance in mammals-an unpaved road to the egg. Nat Rev Mol Cell Biol 7 (2006) 276-285
44. Jeannin P., Bottazzi B., Sironi M., Doni A., Rusnati M., Presta M., et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22 (2005) 551-560
45. Gaziano R., Bozza S., Bellocchio S., Perruccio K., Montagnoli C., Pitzurra L., et al. Anti-aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother 48 (2004) 4414-4421
46. Diniz S.N., Nomizo R., Cisalpino P.S., Teixeira M.M., Brown G.D., Mantovani A., et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 75 (2004) 649-656
47. Vouret-craviari V., Matteucci C., Peri G., Poli G., Introna M., and Mantovani A. Expression of a long pentraxin. PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Infect Immun 65 (1997) 1345-1350
48. Azzurri A., Sow O.Y., Amedei A., Bah B., Diallo S., Peri G., et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7 (2005) 1-8
49. Olesen R., Wejse C., Velez D.R., Bisseye C., Sodemann M., Aaby P., et al. DC-SIGN (CD209). Pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in west. Africans Genes Immun 8 (2007) 456-467
50. Kravitz M.S., and Shoenfeld Y. Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases?. Nat Clin Pract Rheumatol 2 (2006) 481-490
51. Hughes A.L. Protein phylogenies provide evidence of a radical discontinuity between arthropod and vertebrate immune systems. Immunogenetics 47 (1998) 283-296
52. Shrive A.K., Metcalfe A.M., Cartwright J.R., and Greenhough T.J. C-reactive protein and SAP like pentraxin are both present in Limulus polyphemus haemolymph: crystal structure of Limulus SAP. J Mol Biol 290 (1999) 997-1008
53. Lee T.H., Lee G.W., Ziff E.B., and Vilcek J. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblast. Mol Cell Biol 10 (1990) 1982-1988
54. Basile A., Sica A., d'Aniello E., Breviario F., Garrido G., Castellano M., et al. Characterization of the promoter for the human long pentraxin PTX3. Role of NF kappa B in tumour necrosis factor-alpha and interleukin-1beta regulation. J Biol Chem 272 (1997) 8172-8178
55. Lange L.A., Carlson C.S., Hindorff L.A., Lange E.M., Walston J., Durda J.P., et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296 (2006) 2703-2711
56. Vogt B., Führnrohr B., Müller R., and Sheriff A. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 40 (2007) 295-298
57. Russell A.I., Cunninghame Graham D.S., Shepherd C., Roberton C.A., Whittaker J., Meeks J., et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 13 (2004) 137-147
58. Gaipl U.S., Kuhn A., Sheriff A., Munoz L.E., Franz S., Voll R.E., et al. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 9 (2006) 173-187
59. Bansal S., and Ridker P.M. Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C reactive protein. Am J Cardiol 99 (2007) 1500-1503
60. Salustri A., Garlanda C., Hirsch E., De Acetis M., Maccagno A., Bottazzi B., et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in vivo fertilization. Development 131 (2004) 1577-1586
61. Doni A., Peri G., Chieppa M., Allavena P., Pasqualini F., Vago L., et al. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur J Immunol 33 (2003) 2886-2893
62. Shelton R.C., Liang S., Liang P., Chakrabarti A., Manier D.H., and Sulser F. Differential expression of pentraxin 3 in fibroblasts from patients with major depression. Neuropsychopharmacology 29 (2004) 126-132
63. Nauta A.J., de Haij S., Bottazzi B., Mantovani A., Borrias M.C., Aten J., et al. Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int 67 (2005) 543-553
64. Doni A., Michela M., Bottazzi B., Peri G., Valentino S., Polentarutti N., et al. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol 79 (2006) 797-802
65. Szucs G., Timar O., Szekanecz Z., Der H., Kerekes G., Szamosi S., et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis, relevance for prevention of vascular complications. Rheumatology (Oxford) 46 (2007) 759-762
66. Polentarutti N., Picardi G., Basile A., Cenzuales S., Rivolta A., Matteucci C., et al. Interferon-gamma inhibits expression of the long pentraxin PTX3 in human monocytes. Eur J Immunol 28 (1998) 496-501
67. Du Clos T.W., and Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res 30 (2004) 261-277
68. Polentarutti N., Bottazzi B., Di Santo E., Blasi E., Agnello D., Ghezzi P., et al. Inducible expression of the long pentraxin PTX3 in the central nervous system. J Neuroimmunol 106 (2000) 87-94
69. Hossain M.A., Russell J.C., O'Brien R., and Laterra J. Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. J Neurosci 24 (2004) 4187-4196
70. Ravizza T., Moneta D., Bottazzi B., Peri G., Garlanda C., Hirsch E., et al. Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration. Neuroscience 105 (2001) 43-53
71. Napoleone E., Di Santo A., Bastone A., Peri G., Mantovani A., de Gaetano G., et al. Long pentraxin PTX3 up regulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 22 (2002) 782-787
72. Napoleone E., Di Santo A., Peri G., Mantovani A., de Gaetano G., Donati M.B., et al. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leukoc Biol 76 (2004) 203-209
73. Rolph M.S., Zimmer S., Bottazzi B., Garlanda C., Mantovani A., and Hansson G.K. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22 (2002) 10-14
74. Soares A.C., Souza D.G., Pinho V., Vieira A.T., Nicoli J.R., Cunha F.Q., et al. Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice. Microbes Infect 8 (2006) 1321-1329
75. Sherer Y., and Shoenfeld Y. Atherosclerosis. Ann Rheum Dis 61 (2002) 97-99
76. Doria A., Sherer Y., Meroni P.L., and Shoenfeld Y. Inflammation and accelerated atherosclerosis: basic mechanisms. Rheum Dis Clin North Am 31 (2005) 355-362
77. George J., Afek A., Gilburd B., Harats D., and Shoenfeld Y. Autoimmunity in atherosclerosis: lessons from experimental models. Lupus 9 (2000) 223-227
78. Hahn B.H., Grossman J., Chen W., and McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28 (2007) 69-75
79. Manzi S., Meilahn E.N., Rairie J.E., Conte C.G., Medsger T.A., Jansen-McWilliams L., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145 (1997) 408-415
80. Tabuchi M., Inoue K., Usui-Kataoka H., Kobayashi K., Teramoto M., Takasugi K., et al. The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. J Lipid Res 48 (2007) 768-781
81. Klouche M., Peri G., Knabbe C., Eckstein H.H., Schmid F.X., Schmitz G., et al. Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 175 (2004) 221-228
82. Bosutti A., Grassi G., Zanetti M., Aleksova A., Zecchin M., Sinagra G., et al. Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66ShcA in pacemaker-implanted patients. Clin Exp Med 7 (2007) 16-23
83. Per G., Introna M., Corradi D., Iacuitti G., Signorini S., Avanzini F., et al. PTX3. A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 102 (2000) 636-641
84. Muller B., Peri G., Doni A., Torri V., Landmann R., Bottazzi B., et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 29 (2001) 1404-1407
85. Luchetti M.M., Piccinini G., Mantovani A., Peri G., Matteucci C., Pomponio G., et al. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol 119 (2000) 196-202
86. Bevelacqua V., Libra M., Mazzarino M.C., Gangemi P., Nicotra G., Curatolo S., et al. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients. Int J Mol Med 18 (2006) 415-423
87. Luchetti M.M., Sambo P., Majlingová P., Svegliati Baroni S., Peri G., Paroncini P., et al. Scleroderma fibroblasts constitutively express the long pentraxin PTX3. Clin Exp Rheumatol 22 (2004) S66-S72
88. Van Rossum A.P., Pas H.H., Fazzini F., Huitema M.G., Limburg P.C., Jonkman M.F., et al. Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis. Arthritis Rheum 54 (2006) 986-991
89. Molloy E.S., and Langford C.A. Advances in the treatment of small vessel vasculitis. Rheum Dis Clin North Am 32 (2006) 157-172
90. Bussolati B., Peri G., Salvidio G., Verzola D., Mantovani A., and Camussi G. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. J Immunol 170 (2003) 1466-1472
91. Chen K.R., Sakamoto M., Ikemoto K., Abe R., and Shimizu H. Granulomatous arteritis in cutaneous lesions of Churg-Strauss syndrome. J Cutan Pathol 34 (2007) 330-337
92. van Rossum A.P., Limburg P.C., and Kallenberg C.G. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis. Ann NY Acad Sci 1051 (2005) 1-11
93. Solomon H.D., Karlson W.E., Rimm B.E., Cannuscio C.C., Mandl A.L., Manson J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107 (2003) 1303-1307
94. Torres J.L., and Ridker P.M. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 18 (2003) 471-478
95. Enzenauer R.J., Collier D.H., and Lopez L.R. Anticardiolipin antibodies in scleroderma. J Clin Rheumatol 12 (2006) 324-326
96. Peng S.L. Neutrophil apoptosis in autoimmunity. J Mol Med 84 (2006) 122-125
97. Carlson J.A., and Chen K.R. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am J Dermatopathol 28 (2006) 486-506
98. Rovere-Querini P., Castiglioni M.T., Sabbadini M.G., and Manfredi A.A. Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity 40 (2007) 290-294
99. De Falco M., Penta R., Laforgia V., Cobellis L., and De Luca A. Apoptosis and human placenta: expression of proteins belonging to different apoptotic pathways during pregnancy. J Exp Clin Cancer Res 24 (2005) 25-33
100. Rovere-Querini P., Antonacci S., Dell'Antonio G., Angeli A., Almirante G., Cin E.D., et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preclampsy. Obstet Gynecol 108 (2006) 148-155
101. Cetin I., Cozzi V., Pasqualini F., Nebuloni M., Garlanda C., Vago L., et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preclampsy and intrauterine growth restriction. Am J Obstet Gynecol 194 (2006) 1347-1353
102. Brull D.J., Serrano N., Zito F., Jones L., Montgomery H.E., Rumley A., et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23 (2003) 2063-2069
103. Toloza S.M., Uribe A.G., McGwin G., Alarcon G.S., Fessler B.J., Bastian H.M., et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 50 (2004) 3947-3957
104. Farzaneh-Far A., and Roman M.J. Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Pract 59 (2005) 823-824
105. Arici M., and Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?. Kidney Int 59 (2001) 407-414
106. Van Doornum S., McColl G., and Wicks I.P. Accelerated atherosclerosis: an extra-articular feature of rheumatoid arthritis?. Arthritis Rheum 46 (2002) 862-873
107. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103 (2001) 1813-1818
108. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
109. Sakkinen P., Abbott R.D., Curb J.D., Rodriguez B.L., Yano K., and Tracy R.P. C-reactive protein and myocardial infarction. J Clin Epidemiol 55 (2002) 445-451
110. Morrow D.A., Rifai N., Antman E.M., Weiner D.L., McCabe C.H., Cannon C.P., et al. C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 31 (1998) 1460-1465